NHS England has today announced that, for the first time, eligible men with early prostate cancer will be offered pioneering therapy known as SABR on the NHS, which delivers a higher dose to the ...
DELRAY BEACH, Fla., April 2, 2026 /PRNewswire/ -- PanGIA Biotech, Inc. ("PanGIA") announced a peer-reviewed clinical study published in Diagnostics, "Urine-Based Machine Learning Assay Detects ...
For many men with prostate cancer, the word “radiotherapy” still conjures up weeks of daily hospital trips: 20 or more ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results